Repatha (evolocumab) - Amgen, Astellas
rosuvastatin - Generic mfg.
Clinical Study of PCSK9 Inhibitors for Preventing Early Neurological Deterioration in Branch Atheromatous Disease (ChiCTR) - Sep 16, 2026 - P4 | N=152 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Dalian Medical University; The First Affiliated Hospital of Dalian Medical University 
New P4 trial • Cardiovascular • Ischemic stroke
https://www.chictr.org.cn/showproj.html?proj=338830
 
Sep 16, 2026
 
Prev Next